PetMed Express, Inc. (PETS)

NMS – Real vaqt narxi. Valyuta: USD

1.76

-0.01 (-0.56%)

Yopilishda: Jun 26, 2026, 4:00 PM EDT

1.76

0.00 (0.00%)

Bozordan keyin: Jun 26, 2026, 7:26 PM EDT

05.06.2026

PETS Q4 Earnings Call Focuses on Turnaround Foundation

PetMed says FY26 reset is working. Its Q4 sales top estimates, margins improve, and it stays independent after $4-$4.25 offers and touts B2B expansion.

02.06.2026

PetMed (PETS) Reports Q4 Loss, Beats Revenue Estimates

PetMed (PETS) came out with a quarterly loss of $0.19 per share versus the Zacks Consensus Estimate of a loss of $0.18. This compares to a loss of $0.56 per share a year ago.

02.06.2026

PetMed Express, Inc. (PETS) Q4 2026 Earnings Call Prepared Remarks Transcript

02.06.2026

PetMeds® Announces Fourth Quarter and Fiscal Year 2026 Financial Results

DELRAY BEACH, Fla., June 02, 2026 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ: PETS) today announced its financial results for its fourth quarter and fiscal year ended March 31, 2026.

29.05.2026

PetMed Express, Inc. to Report Fourth Quarter and Fiscal Year 2026 Financial Results on Tuesday, June 2, 2026

DELRAY BEACH, Fla., May 29, 2026 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (Nasdaq: PETS) today announced it will report financial results for the fourth quarter and fiscal year ended March 31, 2026, on Tuesday, June 2, 2026 after market close. The Company will host a conference call and webcast to discuss these results at 4:30pm Eastern Time on the same day.

22.04.2026

PetMeds announces strategic partnership with Rural King to launch pet pharmacy offering across retail and digital channels

Collaboration expands access to affordable pet medications for rural communities nationwide Collaboration expands access to affordable pet medications for rural communities nationwide

08.04.2026

PetMed Express, Inc. Investigated by the Portnoy Law Firm

LOS ANGELES, April 08, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises PetMed Express , Inc. , (“ PetMed " or the "Company") ( NASDAQ : PETS ) investors that the firm has initiated an investigation into possible securities fraud, and may file a class action on behalf of investors.

Videolar

No Data

There is no data to display

Press-relizlar

02.06.2026

PetMeds® Announces Fourth Quarter and Fiscal Year 2026 Financial Results

22.04.2026

PetMeds announces strategic partnership with Rural King to launch pet pharmacy offering across retail and digital channels

Collaboration expands access to affordable pet medications for rural communities nationwide Collaboration expands access to affordable pet medications for rural communities nationwide

08.04.2026

PetMed Express, Inc. Investigated by the Portnoy Law Firm

08.01.2026

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed Express, Inc. - PETS

NEW YORK, Jan. 8, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of PetMed Express, Inc. ("PetMed" or the "Company") (NASDAQ: PETS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

PetMed Express, Inc. (PETS)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

PetMed Express, Inc. (PETS)

PETS Q4 Earnings Call Focuses on Turnaround Foundation

PetMed (PETS) Reports Q4 Loss, Beats Revenue Estimates

PetMed Express, Inc. (PETS) Q4 2026 Earnings Call Prepared Remarks Transcript

PetMeds® Announces Fourth Quarter and Fiscal Year 2026 Financial Results

PetMed Express, Inc. to Report Fourth Quarter and Fiscal Year 2026 Financial Results on Tuesday, June 2, 2026

PetMeds announces strategic partnership with Rural King to launch pet pharmacy offering across retail and digital channels

PetMed Express, Inc. Investigated by the Portnoy Law Firm

Videolar

No Data

Press-relizlar

PetMeds® Announces Fourth Quarter and Fiscal Year 2026 Financial Results

PetMeds announces strategic partnership with Rural King to launch pet pharmacy offering across retail and digital channels

PetMed Express, Inc. Investigated by the Portnoy Law Firm

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed Express, Inc. - PETS

PETS Q4 Earnings Call Focuses on Turnaround Foundation

PetMed (PETS) Reports Q4 Loss, Beats Revenue Estimates

PetMed Express, Inc. (PETS) Q4 2026 Earnings Call Prepared Remarks Transcript

PetMeds® Announces Fourth Quarter and Fiscal Year 2026 Financial Results

PetMed Express, Inc. to Report Fourth Quarter and Fiscal Year 2026 Financial Results on Tuesday, June 2, 2026

PetMeds announces strategic partnership with Rural King to launch pet pharmacy offering across retail and digital channels

PetMed Express, Inc. Investigated by the Portnoy Law Firm

Videolar

No Data

Press-relizlar

PetMeds® Announces Fourth Quarter and Fiscal Year 2026 Financial Results

PetMeds announces strategic partnership with Rural King to launch pet pharmacy offering across retail and digital channels

PetMed Express, Inc. Investigated by the Portnoy Law Firm

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed Express, Inc. - PETS

Search stocks

PetMed Express, Inc. (PETS)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

PetMed Express, Inc. (PETS)

PETS Q4 Earnings Call Focuses on Turnaround Foundation

PetMed (PETS) Reports Q4 Loss, Beats Revenue Estimates

PetMed Express, Inc. (PETS) Q4 2026 Earnings Call Prepared Remarks Transcript

PetMeds® Announces Fourth Quarter and Fiscal Year 2026 Financial Results

PetMed Express, Inc. to Report Fourth Quarter and Fiscal Year 2026 Financial Results on Tuesday, June 2, 2026

PetMeds announces strategic partnership with Rural King to launch pet pharmacy offering across retail and digital channels

PetMed Express, Inc. Investigated by the Portnoy Law Firm

Videolar

No Data

Press-relizlar

PetMeds® Announces Fourth Quarter and Fiscal Year 2026 Financial Results

PetMeds announces strategic partnership with Rural King to launch pet pharmacy offering across retail and digital channels

PetMed Express, Inc. Investigated by the Portnoy Law Firm

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed Express, Inc. - PETS

PETS Q4 Earnings Call Focuses on Turnaround Foundation

PetMed (PETS) Reports Q4 Loss, Beats Revenue Estimates

PetMed Express, Inc. (PETS) Q4 2026 Earnings Call Prepared Remarks Transcript

PetMeds® Announces Fourth Quarter and Fiscal Year 2026 Financial Results

PetMed Express, Inc. to Report Fourth Quarter and Fiscal Year 2026 Financial Results on Tuesday, June 2, 2026

PetMeds announces strategic partnership with Rural King to launch pet pharmacy offering across retail and digital channels

PetMed Express, Inc. Investigated by the Portnoy Law Firm

Videolar

No Data

Press-relizlar

PetMeds® Announces Fourth Quarter and Fiscal Year 2026 Financial Results

PetMeds announces strategic partnership with Rural King to launch pet pharmacy offering across retail and digital channels

PetMed Express, Inc. Investigated by the Portnoy Law Firm

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed Express, Inc. - PETS